Caren van Roekel

287 Discussion 84. Braat AJAT, Kappadath SC, Bruijnen RCG, Van den Hoven AF, Mahvash A, De Jong HWAM, et al. Adequate SIRT activity dose is as important as adequate chemotherapy dose. Lancet Oncol. 2017;18:e636. 85. Garin E. A multicentric and randomized study demonstrating the impact of MAA based dosimetry on tumor response in SIRT for HCC. 2019 [cited 2019 December 12]; Available from: https://www. eventscribe.com/2019/GEST/fsPopup. asp?Mode=presInfo&PresentationID =521844. 86. Flamen P, Vanderlinden B, Delatte P, Ghanem G, Ameye L, Van Den Eynde M, et al. Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with Yttrium-90 labeled resin microspheres. Phys Med Biol. 2008;53(22):6591-603. Epub 2008/11/04. 87. van den Hoven AF, Rosenbaum CE, Elias SG, de Jong HW, Koopman M, Verkooijen HM, et al. Insights into the Dose-Response Relationship of Radioembolization with Resin 90Y-Microspheres: A Prospective Cohort Study in Patients with Colorectal Cancer Liver Metastases. J Nucl Med. 2016;57(7):1014-9. Epub 2016/02/26. 88. Levillain H, Duran Derijckere I, Marin G, Guiot T, Vouche M, Reynaert N, et al. (90)Y-PET/CT-based dosimetry after selective internal radiation therapy predicts outcome in patients with liver metastases from colorectal cancer. EJNMMI research. 2018;8(1):60. Epub 2018/07/15. 89. Willowson KP, Hayes AR, Chan DLH, Tapner M, Bernard EJ, Maher R, et al. Clinical and imaging-based prognostic factors in radioembolisation of liver metastases from colorectal cancer: a retrospective exploratory analysis. EJNMMI research. 2017;7(1):46. Epub 2017/05/26. 90. Abbott EM, Falzone N, Lee BQ, Kartsonaki C, Winter H, Greenhalgh TA, et al. The Impact of Radiobiologically- Informed Dose Prescription on the Clinical Benefit of Yttrium-90 SIRT in Colorectal Cancer Patients. J Nucl Med. 2020. Epub 2020/05/03. 91. Cremonesi M, Chiesa C, Strigari L, Ferrari M, Botta F, Guerriero F, et al. Radioembolization of hepatic lesions from a radiobiology and dosimetric perspective. Front Oncol. 2014;4:210. Epub 2014/09/06. 92. Tirumani SH, Kim KW, Nishino M, Howard SA, Krajewski KM, Jagannathan JP, et al. Update on the role of imaging in management of metastatic colorectal cancer. RadioGraphics. 2014;34:1908- 28. 93. van den Hoven AF, Lam MG, Jernigan S, van den Bosch MA, Buckner GD. Innovation in catheter design for intra- arterial liver cancer treatments results in favorable particle-fluid dynamics. J Exp Clin Cancer Res. 2015;34:74. Epub 2015/08/02. 10